Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Trek- This was questioning Muir I used TM (sorry)
There was some new investors on the chat board.
I read your statements and totally agree with them.
He was naming me a liar etc. Not really fussed but a little uncalled for.
Good luck with your trading, sorry for any confusion.
Robin- I'm sorry I dignity answer your question correctly. The cover tests are due soon. (June)
However the Standalone pre CISION platform is this year. Affirmer platform 2021 and hybrid TMAC 2022.
These approvals may come sooner depending upon what plays out here over the next coming weeks/months.
Good luck with your investment
It will be the rapid tests that meet the standards. It will be in Cytiva hands, as of yet no news. Although there is a lot of anticipation on this board for that news to land very soon.
The lab tests are in development as per todays RNS
Hope this helps
Captain- COMPLETELY agree with your comments. .This news is very positive. Once again highlighting the huge potential for the products in the coming period. In addition to possible worldwide future demand.
American partnerships too.
This is the clinical/ lab side.
Adeptrix's novel BAMS platform combines enrichment of the sample to improve sensitivity with the power of mass-spectrometry to improve specificity. Hundreds of samples per day can be analysed by a single technician using BAMS, exceeding the capacity of single PCR machine, making BAMS a very attractive high throughput technique for COVID-19 screening in the clinical setting.
Good news but Cytiva "pregnancy style strips " is the BIGGIE